From the AGA Journals
From the AGA Journals
Smoking and alcohol raise risk of second cancer in squamous cell carcinoma
Although alcohol and smoking are known risk factors, the effects of cessation are not yet as well studied, according to investigators.
From the AGA Journals
Flexible sigmoidoscopy ADR linked to long-term survival
The screening program had no apparent effect on incidence and mortality of proximal cancers.
From the Journals
High GI spending reveals research, public health need
The top five most costly conditions were biliary tract diseases, esophageal disorders, abdominal pain, abdominal hernias, and diverticular disease...
News
US Multi-Society Task Force lowers recommended CRC screening age
Although controlled data demonstrating the effects of earlier screening are lacking, the nine experts predicted that expanded screening would...
From the Journals
AGA Clinical Practice Update: Commentary on surveillance after ESD for dysplasia and early-stage GI cancer
Proposed surveillance intervals and strategies are necessary following ESD considered pathologically curative to help steer clinical practice and...
From the AGA Journals
ESD vs. cEMR: Rates of complete remission in Barrett’s compared
The study found similar rates of complete remission of intestinal metaplasia between the ESD and cEMR treatment groups at 2 years.
From the AGA Journals
COVID-19 vaccines: Lower serologic response among IBD, rheumatic diseases
Patients with immune-mediated inflammatory diseases urged to get full mRNA vaccine series without delay and possibly a third dose.
From the AGA Journals
Human CRP protects against acetaminophen-induced liver injury in mice
NAC is effective during only the early phases of the acetaminophen-induced liver injury, whereas human CRP was still highly effective in this...
From the Journals
AGA Clinical Care Pathway: Screening, diagnosis, and treatment of NAFLD and NASH
The authors recommended a four-step screening process for NAFLD/NASH based on available literature and clinical experience.
From the AGA Journals
Novel blood-based panel highly effective for early-stage HCC
A test like this could help enhance guideline-recommended surveillance methods used for at-risk patients.